Leprosy Borderline

Leprosy Borderline: Understanding and Aspects of the Disease

Borderline leprosy, also known as BB leprosy, D leprosy or dimorphic leprosy, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. This disease affects the nervous system, skin, mucous membranes and other human organs. Borderline leprosy gets its name from its intermediate form between the two main forms of leprosy - lepromatous and tuberculoid.

Borderline leprosy is characterized by a variety of clinical manifestations, which depend on the body's immune response to infection. Most people infected with M. leprae have their immune systems suppress the growth of the bacteria, and they remain carriers without developing the disease. However, in some people, the bacteria cause chronic inflammation, which leads to nerve and tissue damage.

Symptoms of borderline leprosy can range from mild to severe. Early signs may include blotchy skin, loss of sensation and numbness in the affected areas, changes in sweating and hair, and sores and ulcers. As the disease progresses, deformities, loss of partial or complete limb function, and other complications occur.

Borderline leprosy is a disease that has a significant social and psychological impact on patients. In the past, people with leprosy have been stigmatized and isolated due to a lack of understanding about the nature of the disease. However, modern medicine and society strive to overcome these problems and provide support to patients with leprosy.

Treatment for borderline leprosy involves the use of antibiotics over a long period of time, usually several years. Early detection and treatment are important in preventing progression of the disease and preventing disability. In addition, rehabilitation interventions such as physiotherapy and psychological support help patients adapt to the effects of the disease and improve their quality of life.

In conclusion, borderline leprosy is a chronic infectious disease that can cause serious health consequences to patients. However, with early detection, adequate treatment and social support, the prognosis and quality of life of people suffering from this disease can be significantly improved. It is important to continue educating and educating the public about borderline leprosy to overcome the stigma and prejudice associated with this disease. Only through the combined efforts of the medical community, government agencies and the public will we be able to fight borderline leprosy and provide a better life for people suffering from this disease.



Borderline leprosy is a disease that is manifested by the appearance of ulcers, scars, lichenification and depigmentation on the skin and mucous membrane. The disease is characterized by a long course and frequent progression. Treatment of borderline leprosy is long-term and requires an integrated approach. The article will discuss information about this disease.

Borderline leprosy. Synonyms

* Leprosy is dimorphic * Dimorphic leprosy * Borderline tuberculous lupus * Degranulous leprosy or endobronchial leprosy.

Definition

The term "leprosy", along with tuberculosis, is one of the infections caused by specific bacteria - Koch bacilli. The bacterium also secretes an enzymatic toxin, which most often manifests itself not only in allergic reactions, but also in specific reactions of the host body - systemic manifestations. As a rule, the patient suffers little from the underlying disease, since the course of tuberculosis is accompanied by damage to other organs, which greatly depletes the body. However, with the disease, the Leprak stick manifests itself in more sluggish, weakly expressed, and sometimes even asymptomatic manifestations, as against the background of sensitization. Recovery occurs rarely and not always in the same person. Relapses are frequent. Almost every case of this form is inevitably associated with contacts with patients with the non-sterile lepromatous form of the tuberculosis bacillus. In some cases, the “borderline” form of leprosy is called the lepromatous type. How can we explain this term? This is the absence of a pronounced clinical picture. The mucous membranes, eyelids and oral cavity of the “borderline” occupy a minimal amount of area, and even then not very clearly defined. The hands and feet are covered with a pronounced grayish-red blush, which is difficult to remove when treated with disinfectants. Babinski figures may not be palpable on the skin. Pityriasis scaly “rhinitis”, or skin fistulas, are possible, but without clear identification of an infiltrative-necrotic plug. The only simple diagnostic test is the Mantoux reaction, which can only serve as a basis for diagnosis. No other evidence in favor of the presence of specific lesions of the tuberculosis type is seen or heard. Only through careful examination of the reactions over the patient's lymph nodes and